The Medicaid Drug Utilization Review (DUR) Program was created by the Omnibus Budget Reconciliation Act (OBRA) of 1990. The main emphasis of the program is to promote patient safety by an increased review and awareness of outpatient prescribed drugs. States were encouraged by enhanced federal funding to design and install point-of-sale electronic claims management systems that interface with their Medicaid Management Information Systems (MMIS) operations. The annual report requirement provides an excellent measurement tool to assess how well patient safety, provider prescribing habits and dollars saved by avoidance of problems such as drug-drug interactions, drug-disease interactions, therapeutic duplication, and over-prescribing by providers. Downloads | There are no Downloads
| Related Links Inside CMS | There are no Related Links Inside CMS
| Related Links Outside CMS | ![External Linking Policy](https://webarchive.library.unt.edu/web/20090118134449im_/https://www.cms.hhs.gov/images/disclaimer.gif) | There are no Related Links Outside CMS
|
Page Last Modified: 12/14/2005 12:00:00 AM
Help with File Formats and Plug-Ins
Submit Feedback
|